Answers are grounded in this paper and cite their sources.
This framework demonstrates cognitive enhancement using AI in a structured system, suggesting a scalable and equitable approach.
This paper specifies WEBBPEUTICS and its implementation system, the Global Intelligence Augmentation System (GIAS)—a regulated, evidence-based infrastructure applying the pharmaceutical model to human cognitive augmentation through artificial intelligence. The central thesis is that artificial intelligence has reached the capability threshold at which it can compensate for specific human cognitive deficiencies, but the absence of a structured diagnostic-prescriptive delivery infrastructure renders this capability inaccessible, inequitably distributed, and unmeasurable in its outcomes. GIAS resolves this limitation through six integrated layers: an independent governance and standards body (Global Intelligence Standards Board, GISB); a validated multi-dimensional diagnostic engine measuring five cognitive dimensions; a prescription engine producing structured AI treatment plans with defined dosage, tapering, and safety manifests; a tiered AI formulary (WEBBICATION); a secure deployment infrastructure (WEBBFACTURING); and a continuous monitoring and feedback optimization system. An adaptive security layer, modeled on a biological immune system, provides collective, self-learning defense across the infrastructure. The paper advances five primary contributions: (1) the WEBBPEUTICS framework as a complete specification of AI as personalized cognitive medicine; (2) the Total Intelligence Score (TIS), a five-dimensional, dynamically updated, culturally normed cognitive assessment system; (3) the Cognitive Twin, a persistent computational model of an individual’s evolving cognitive profile; (4) an adaptive security architecture enabling global, sub-200ms threat response with permanent threat memory; and (5) a full implementation roadmap, governance structure, and economic model demonstrating global scalability within a five-year horizon
No takes yet. Share an insight, caveat, or question.
Rashon Rahming (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: